These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10607256

  • 1. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
    Mutchnick MG, Lindsay KL, Schiff ER, Cummings GD, Appelman HD, Peleman RR, Silva M, Roach KC, Simmons F, Milstein S, Gordon SC, Ehrinpreis MN.
    J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
    You J, Zhuang L, Cheng HY, Yan SM, Yu L, Huang JH, Tang BZ, Huang ML, Ma YL, Chongsuvivatwong V, Sriplung H, Geater A, Qiao YW, Wu RX.
    World J Gastroenterol; 2006 Nov 07; 12(41):6715-21. PubMed ID: 17075991
    [Abstract] [Full Text] [Related]

  • 3. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.
    Zavaglia C, Severini R, Tinelli C, Franzone JS, Airoldi A, Tempini S, Bettale G, Ideo G.
    Dig Dis Sci; 2000 Apr 07; 45(4):690-6. PubMed ID: 10759236
    [Abstract] [Full Text] [Related]

  • 4. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].
    You J, Zhuang L, Cheng HY, Yan SM, Qiao YW, Huang JH, Tang BZ, Ma YL, Wu GB, Qu JY, Wu RX.
    J Chin Med Assoc; 2005 Feb 07; 68(2):65-72. PubMed ID: 15759817
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
    Yang YF, Zhao W, Zhong YD, Yang YJ, Shen L, Zhang N, Huang P.
    Antiviral Res; 2008 Feb 07; 77(2):136-41. PubMed ID: 18078676
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N.
    J Gastroenterol Hepatol; 2002 Apr 07; 17(4):409-14. PubMed ID: 11982721
    [Abstract] [Full Text] [Related]

  • 7. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
    Arase Y, Tsubota A, Suzuki Y, Suzuki F, Kobayashi M, Someya T, Akuta N, Hosaka T, Saitoh S, Ikeda K, Kobayashi M, Kumada H.
    Intern Med; 2003 Oct 07; 42(10):941-6. PubMed ID: 14606705
    [Abstract] [Full Text] [Related]

  • 8. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
    Lau GK, Nanji A, Hou J, Fong DY, Au WS, Yuen ST, Lin M, Kung HF, Lam SK.
    J Viral Hepat; 2002 Jul 07; 9(4):280-7. PubMed ID: 12081605
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
    Kim BH, Lee YJ, Kim W, Yoon JH, Jung EU, Park SJ, Kim YJ, Lee HS.
    Scand J Gastroenterol; 2012 Sep 07; 47(8-9):1048-55. PubMed ID: 22726105
    [Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P, Cursaro C, Gramenzi A, Zavagliz C, Rezakovic I, Altomare E, Severini R, Franzone JS, Albano O, Ideo G, Bernardi M, Gasbarrini G.
    Hepatology; 1996 Oct 07; 24(4):774-7. PubMed ID: 8855175
    [Abstract] [Full Text] [Related]

  • 11. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].
    Ling N, Zhou Z, Zhang DZ, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2007 May 07; 15(5):346-9. PubMed ID: 17524266
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.
    Lee HW, Lee JI, Um SH, Ahn SH, Chang HY, Park YK, Hong SP, Moon YM, Han KH.
    J Gastroenterol Hepatol; 2008 May 07; 23(5):729-35. PubMed ID: 18410608
    [Abstract] [Full Text] [Related]

  • 13. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
    Chan HL, Wang H, Niu J, Chim AM, Sung JJ.
    Antivir Ther; 2007 May 07; 12(3):345-53. PubMed ID: 17591024
    [Abstract] [Full Text] [Related]

  • 14. A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.
    Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, Suresh S, Wu YJ, Machin D, Lim CC, Fock KM, Koay E, Bowden S, Locarnini S, Ishaque SM.
    Antivir Ther; 2006 May 07; 11(2):245-53. PubMed ID: 16640105
    [Abstract] [Full Text] [Related]

  • 15. Thymalfasin for the treatment of chronic hepatitis B.
    Chien RN, Liaw YF.
    Expert Rev Anti Infect Ther; 2004 Feb 07; 2(1):9-16. PubMed ID: 15482167
    [Abstract] [Full Text] [Related]

  • 16. Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B.
    Zhuang L, You J, Tang BZ, Ding SY, Yan KH, Peng D, Zhang YM, Zhang L.
    World J Gastroenterol; 2001 Jun 07; 7(3):407-10. PubMed ID: 11819800
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J, Sun X, Fang J, Wang C, Han G, Ren W.
    Clin Res Hepatol Gastroenterol; 2017 Dec 07; 41(6):635-643. PubMed ID: 28438570
    [Abstract] [Full Text] [Related]

  • 18. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
    Lau GK.
    J Gastroenterol Hepatol; 2000 May 07; 15 Suppl():E46-52. PubMed ID: 10921382
    [Abstract] [Full Text] [Related]

  • 19. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ, Rijckborst V, Cakaloglu Y, Simon K, Heathcote EJ, Tabak F, Mach T, Boucher CA, Hansen BE, Zeuzem S, Janssen HL.
    Antivir Ther; 2012 May 07; 17(1):9-17. PubMed ID: 22267464
    [Abstract] [Full Text] [Related]

  • 20. A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection.
    Gilson RJ, Chopra KB, Newell AM, Murray-Lyon IM, Nelson MR, Rice SJ, Tedder RS, Toole J, Jaffe HS, Weller IV.
    J Viral Hepat; 1999 Sep 07; 6(5):387-95. PubMed ID: 10607255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.